» Articles » PMID: 29497978

Repeated Clostridium Difficile Infection After Living Donor Liver Transplantation

Overview
Specialty Gastroenterology
Date 2018 Mar 3
PMID 29497978
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Liver transplant recipients are considered to be at high risk for Clostridium difficile infection, with an incidence of 2.7-8.0%, which is three times higher than that among other patients. A case of a patient who suffered from pseudomembranous colitis five times after living donor liver transplantation is reported. A 60-year-old woman underwent splenectomy and living donor liver transplantation using the left lobe of her spouse for primary biliary cirrhosis. The patient made a satisfactory recovery, except for splenic vein thrombosis. She was discharged on postoperative day 36; however, she developed pseudomembranous colitis due to Clostridium difficile infection five times within 6 months after transplant and was treated with oral vancomycin each time. At the fifth recurrence of pseudomembranous colitis, the patient received vancomycin taper treatment, dietary counseling, and repeat instructions regarding hand hygiene and house cleaning. The patient recovered and is currently well without recurrence of Clostridium difficile infection 36 months after living donor liver transplantation.

Citing Articles

infection in liver cirrhosis patients: A population-based study in United States.

Sahra S, Abureesh M, Amarnath S, Alkhayyat M, Badran R, Jahangir A World J Hepatol. 2021; 13(8):926-938.

PMID: 34552699 PMC: 8422922. DOI: 10.4254/wjh.v13.i8.926.

References
1.
Stelzmueller I, Goegele H, Biebl M, Wiesmayr S, Berger N, Tabarelli W . Clostridium difficile colitis in solid organ transplantation--a single-center experience. Dig Dis Sci. 2007; 52(11):3231-6. DOI: 10.1007/s10620-007-9770-z. View

2.
Hashimoto M, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J . Clostridium difficile-associated diarrhea after living donor liver transplantation. World J Gastroenterol. 2007; 13(14):2072-6. PMC: 4319127. DOI: 10.3748/wjg.v13.i14.2072. View

3.
Neff G, Zacharias V, Kaiser T, Gaddis A, Kemmer N . Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series. Liver Transpl. 2010; 16(8):960-3. DOI: 10.1002/lt.22092. View

4.
Rochon C, Kardashian A, Mahadevappa B, Gunasekaran G, Sharma J, Sheiner P . Liver graft failure and hyperbilirubinemia in liver transplantation recipients after Clostridium difficile infection. Transplant Proc. 2011; 43(10):3819-23. DOI: 10.1016/j.transproceed.2011.08.098. View

5.
Albright J, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R . Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int. 2007; 20(10):856-66. DOI: 10.1111/j.1432-2277.2007.00530.x. View